GlassScriptPrepare for your visit
Elizabeth Bond
Christiansburg, VA · NPI 1972920254
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$6,880.47
in general payments reported to CMS, 2019-2025 · $1,636 in 2025
The $1,636 reported for 2025 was more than what 92% of providers received nationally.
Who reported paying
General payments only, top 6 by amount.
- Lilly USA, LLC $1,242.39
- Novo Nordisk INC $1,130.77
- Abbvie INC. $583.12
- Boehringer Ingelheim Pharmaceuticals, INC. $494.35
- Sanofi-Aventis U.S. LLC $459.62
- Ibsa Pharma INC. $395.19
Drugs and devices associated with these payments
Ozempic Mounjaro Jardiance Tirosint Rybelsus Synthroid Tzield Licart Zepbound Omnipod Trulicity Unithroid
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Elizabeth Bond listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/7226115/elizabeth-bond